TERAZOSIN

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Details

Stereochemistry	RACEMIC
Molecular Formula	C19H25N5O4
Molecular Weight	387.4329
Optical Activity	( + / - )
Defined Stereocenters	0 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of TERAZOSIN

Structure Search

SMILES

COC1=CC2=NC(=NC(N)=C2C=C1OC)N3CCN(CC3)C(=O)C4CCCO4

InChI

InChIKey=VCKUSRYTPJJLNI-UHFFFAOYSA-N

InChI=1S/C19H25N5O4/c1-26-15-10-12-13(11-16(15)27-2)21-19(22-17(12)20)24-7-5-23(6-8-24)18(25)14-4-3-9-28-14/h10-11,14H,3-9H2,1-2H3,(H2,20,21,22)

HIDE SMILES / InChI

Molecular Formula	C19H25N5O4
Molecular Weight	387.4329
Charge	0
Count

Stereochemistry	RACEMIC
Additional Stereochemistry	No
Defined Stereocenters	0 / 1
E/Z Centers	0
Optical Activity	( + / - )

Approval Year

Substance Class	Chemical Created by `admin` on `Fri Dec 15 16:10:24 UTC 2023` Edited by `admin` on `Fri Dec 15 16:10:24 UTC 2023`
Record UNII	8L5014XET7
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

TERAZOSIN

Official Name

English

Terazosin [WHO-DD]

Common Name

English

TERAZOSIN [MI]

Common Name

English

terazosin [INN]

Common Name

English

TERAZOCIN

Systematic Name

English

TERAZOSABB

Brand Name

English

TERAZOSIN [VANDF]

Common Name

English

Classification Tree Code System Code

WHO-VATC

QG04CA03

Created by admin on Fri Dec 15 16:10:24 UTC 2023 , Edited by admin on Fri Dec 15 16:10:24 UTC 2023

WHO-ATC

G04CA03

Created by admin on Fri Dec 15 16:10:24 UTC 2023 , Edited by admin on Fri Dec 15 16:10:24 UTC 2023

NDF-RT

N0000000099

Created by admin on Fri Dec 15 16:10:24 UTC 2023 , Edited by admin on Fri Dec 15 16:10:24 UTC 2023

LIVERTOX

NBK548096

Created by admin on Fri Dec 15 16:10:24 UTC 2023 , Edited by admin on Fri Dec 15 16:10:24 UTC 2023

NDF-RT

N0000175553

Created by admin on Fri Dec 15 16:10:24 UTC 2023 , Edited by admin on Fri Dec 15 16:10:24 UTC 2023

NCI_THESAURUS

C29713

Created by admin on Fri Dec 15 16:10:24 UTC 2023 , Edited by admin on Fri Dec 15 16:10:24 UTC 2023

Code System Code Type Description

RXCUI

37798

Created by admin on Fri Dec 15 16:10:24 UTC 2023 , Edited by admin on Fri Dec 15 16:10:24 UTC 2023

PRIMARY

RxNorm

IUPHAR

7302

Created by admin on Fri Dec 15 16:10:24 UTC 2023 , Edited by admin on Fri Dec 15 16:10:24 UTC 2023

PRIMARY

SMS_ID

100000082702

Created by admin on Fri Dec 15 16:10:24 UTC 2023 , Edited by admin on Fri Dec 15 16:10:24 UTC 2023

PRIMARY

DRUG CENTRAL

3584

Created by admin on Fri Dec 15 16:10:24 UTC 2023 , Edited by admin on Fri Dec 15 16:10:24 UTC 2023

PRIMARY

CHEBI

9445

Created by admin on Fri Dec 15 16:10:24 UTC 2023 , Edited by admin on Fri Dec 15 16:10:24 UTC 2023

PRIMARY

ChEMBL

CHEMBL611

Created by admin on Fri Dec 15 16:10:24 UTC 2023 , Edited by admin on Fri Dec 15 16:10:24 UTC 2023

PRIMARY

DAILYMED

8L5014XET7

Created by admin on Fri Dec 15 16:10:24 UTC 2023 , Edited by admin on Fri Dec 15 16:10:24 UTC 2023

PRIMARY

DRUG BANK

DB01162

Created by admin on Fri Dec 15 16:10:24 UTC 2023 , Edited by admin on Fri Dec 15 16:10:24 UTC 2023

PRIMARY

NCI_THESAURUS

C61964

Created by admin on Fri Dec 15 16:10:24 UTC 2023 , Edited by admin on Fri Dec 15 16:10:24 UTC 2023

PRIMARY

INN

4843

Created by admin on Fri Dec 15 16:10:24 UTC 2023 , Edited by admin on Fri Dec 15 16:10:24 UTC 2023

PRIMARY

EPA CompTox

DTXSID3023639

Created by admin on Fri Dec 15 16:10:24 UTC 2023 , Edited by admin on Fri Dec 15 16:10:24 UTC 2023

PRIMARY

MESH

C041226

Created by admin on Fri Dec 15 16:10:24 UTC 2023 , Edited by admin on Fri Dec 15 16:10:24 UTC 2023

PRIMARY

EVMPD

SUB10907MIG

Created by admin on Fri Dec 15 16:10:24 UTC 2023 , Edited by admin on Fri Dec 15 16:10:24 UTC 2023

PRIMARY

FDA UNII

8L5014XET7

Created by admin on Fri Dec 15 16:10:24 UTC 2023 , Edited by admin on Fri Dec 15 16:10:24 UTC 2023

PRIMARY

PUBCHEM

5401

Created by admin on Fri Dec 15 16:10:24 UTC 2023 , Edited by admin on Fri Dec 15 16:10:24 UTC 2023

PRIMARY

MERCK INDEX

m10567

Created by admin on Fri Dec 15 16:10:24 UTC 2023 , Edited by admin on Fri Dec 15 16:10:24 UTC 2023

PRIMARY

Merck Index

WIKIPEDIA

TERAZOSIN

Created by admin on Fri Dec 15 16:10:24 UTC 2023 , Edited by admin on Fri Dec 15 16:10:24 UTC 2023

PRIMARY

CAS

63590-64-7

Created by admin on Fri Dec 15 16:10:24 UTC 2023 , Edited by admin on Fri Dec 15 16:10:24 UTC 2023

PRIMARY

LACTMED

Terazosin

Created by admin on Fri Dec 15 16:10:24 UTC 2023 , Edited by admin on Fri Dec 15 16:10:24 UTC 2023

PRIMARY

Related Record Type Details


					P5O3A2DHB2

ALPHA-1D ADRENERGIC RECEPTOR

TARGET -> INHIBITOR


					Q7A4S7HOP4

ALPHA-1B ADRENERGIC RECEPTOR

TARGET -> INHIBITOR


					6D53G0FD0Z

PLASMA PROTEIN FRACTION (HUMAN)

BINDER->LIGAND

Interaction Type:

BINDING

Amount:


					3T7136LE8K

ALPHA-1A ADRENERGIC RECEPTOR

TARGET -> INHIBITOR


					D32S14F082

TERAZOSIN HYDROCHLORIDE

SALT/SOLVATE -> PARENT

Related Record Type Details


					3O886C86WZ

6-O-DESMETHYL TERAZOSIN

METABOLITE -> PARENT

Qualification:

URINE


					48ZH8CHN6M

4-AMINO-2-(4-(4-CARBOXY-2-HYDROXYBUTANOYL)-1-PIPERAZINYL)-6,7-DIMETHOXYQUINAZOLINE

METABOLITE -> PARENT

Qualification:

URINE


					X8C5VTG33W

2,4-DIAMINO-6,7-DIMETHOXYQUINAZOLINE

METABOLITE -> PARENT

Qualification:

URINE


					1X8JI3451K

1-(4-AMINO-6,7-DIMETHOXY-2-QUINAZOLINYL)PIPERAZINE

METABOLITE -> PARENT

Qualification:

URINE

Related Record Type Details


					8L5014XET7

TERAZOSIN

ACTIVE MOIETY

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
Volume of Distribution	PHARMACOKINETIC

Biological Half-life	PHARMACOKINETIC